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Abstract
Background: The Questionnaire to Identify Knee Symptoms (QuIKS) was recently developed to promote activity by
screening for experiences related to early symptoms in people with emergent chronic knee pain problems, such as
osteoarthritis (OA) – like knee pain. The main purpose of the current study was to evaluate measurement properties
of the QuIKS using Rasch analysis in a sample of people with knee symptoms consistent with symptomatic knee
OA.
Method: This study used cross-sectional data. The sample was 200 subjects along the following knee health
continuum: pain-free healthy knees (n = 55) from a university community, knee pain with no knee OA diagnosis
(n = 111) from a university-affiliated medical clinic, and patients with surgeon-diagnosed symptomatic knee OA
awaiting high tibial osteotomy (n = 34) from a sports medicine surgical clinic. The 13-item QuIKS was evaluated for
its factor structure, item- and person-fit, item’s category response structure, differential item functioning by sex and
obesity status, local item dependency, unidimensionality, and test precision. Subsequently, the QuIKS underwent
known-groups analysis and convergent validity with the Knee injury and Osteoarthritis Outcome Score (KOOS).
Results: In the QuIKS, each item’s category response structure was modified. No differential item functioning was
observed. Local item dependency informed the formation of four testlets. This refined QuIKS obtained summary fit
to the Rasch measurement model, unidimensionality, reliability (person separation index = 0.82), and interval-level
scoring. Subsequently, the Rasch-validated QuIKS (QuIKS-R) demonstrated excellent known-groups validity and
good convergent validity with the KOOS (Spearman’s rho = 0.45 to 0.77).
Conclusions: The QuIKS-R provides interval-level quantification of knee symptoms-related experiences in people
with knee symptoms consistent with symptomatic knee OA. Its scores might be useful for clinicians for promoting
activity in individuals with early symptoms consistent with symptomatic knee OA.
Keywords: Outcome assessment, Knee osteoarthritis, Questionnaire, Reliability and validity, Knee pain, Lived
experience
Introduction
Symptomatic knee osteoarthritis (OA) is a chronic
degenerative joint disease in which knee pain and
changes in the joint structure are related to ill-effects
that include physical impairments, activity limitations,
participation restrictions, and reduced quality of life
[1–4]. In the United States of America, the lifetime risk of
developing symptomatic knee OA is up to 23.9 %, depend-
ing on one’s sex, age, and obesity status [3]. The lived
experience of people with knee OA is considered biop-
sychosocial, and is associated with the ill-effects of the
condition [4–8]. Furthermore, measurement of these
experiences might be useful in identifying people with
early stage knee OA symptoms for therapy, because stud-
ies have shown that during the pre-diagnosis stage and
early stages of knee OA as well as when symptomatic knee
OA is recently diagnosed, people appraise, perceive, form
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intentions around, and respond to their knee symptoms in
certain ways [4–8].
One measure, the Questionnaire to Identify Knee
Symptoms (QuIKS), was specifically developed for clin-
ical and research use “to identify emerging knee prob-
lems in people who could benefit from conservative
interventions” (p. 1) by quantifying patient’s experi-
ences [9]. The QuIKS is a 13-item self-administered
discriminative questionnaire [9]. It was developed using
a mixed-methods approach, which aligns with recom-
mendations for scale development by Velozo and col-
leagues [10]. First, its items were generated through
qualitative research that used grounded theory to de-
scribe a process of how people with knee symptoms go
through a cycle of perceiving, forming intentions, and
exhibiting behaviours directed at preventing damage
when engaged in physical activity [5]. This was followed
by rheumatology experts’ consensus, then item reduc-
tion and internal consistency evaluation [9]. However,
construct validation has not been performed for QuIKS.
Also, Velozo and colleagues recommended that Rasch
analysis should be used to determine whether a meas-
ure captures a unidimensional construct, which is a
form of construct validation [10]. This last recommen-
dation was the main purpose of this paper.
In Rasch analysis, observed data are expected to fit the
probabilistic relationship within and between person esti-
mates and item estimates as specified in the Rasch meas-
urement model [11, 12]. Consequently, a questionnaire
with data that fits the Rasch model has a unidimensional
construct, thereby having interval-level measurement
properties as recommended for questionnaires used as
measures [10, 13, 14]. Importantly, compared to ordinal-
level or nominal-level summed scores, interval-level meas-
urement properties allow for making more accurate inter-
pretations on the relative distance between scores on the
scale of a measure [12].
The primary purpose of this study was to evaluate the
factor structure, items’ category response structure,
item- and person-fit, differential item functioning, local
item dependence, overall fit, unidimensionality, and test
precision of the QuIKS using Rasch analysis in a sample
of people with knee symptoms consistent with symp-
tomatic knee OA. Our secondary purpose was to subse-
quently evaluate the known-groups validity and the




This study used cross-sectional data. We recruited sub-
jects into three distinct groups along the following knee
health continuum: pain-free healthy knees (HK), knee
pain with no knee OA diagnosis (KP), and surgeon-
diagnosed knee OA scheduled for high tibial osteotomy
(pre-HTO). Subjects in the HK group self-reported no
knee pain in the past three years and were between the
ages of 20 to 40 years. Subjects in the KP group had ver-
bally complained of knee pain lasting two or more weeks
to their family physician within the previous three years
as recorded in their medical chart and were between the
ages of 40 and 65 years. Subjects in the pre-HTO group
were between the ages of 40 and 65 years. The HK
group was recruited (March 2011 to January 2012) from
a university community through posted paper notices.
The KP group was retrospectively collected from data
collected (April to August 2009) through a university-
affiliated medical clinic using mailed questionnaires as
previously described in the publication on the deve-
lopment of the original QuIKS which used some of
this data [9]. The pre-HTO group was prospectively
collected (March 2011 to January 2012) through a
university-affiliated sports medicine clinic using mailed
questionnaires. Each subject had to be able to read
and understand English to participate in this study.
We excluded persons with gout, rheumatoid arthritis,
chronic low back pain, foot or hip pain, major co-
morbidities, previous knee arthroplasty, or high tibial
osteotomy. These exclusion criteria helped to ensure
that the knee pain and the illness experiences of sub-
jects were consistent with symptomatic knee OA.
Ethics approval was granted by Western University’s
Health Sciences Research Ethics Board. Each partici-
pant provided written informed consent.
Participants
The total sample was 200 subjects along the knee health
continuum. The HK, KP, and pre-HTO group had 55,
111, and 34 subjects, respectively.
Outcome measures
The sample descriptive data included sex, age, body
mass index (BMI), affected knee (unilateral, bilateral, or
none), family history of arthritis (yes or no), and history
of knee injury (yes or no). To indicate the structural se-
verity of knee OA, a single rater recorded the Kellgren
and Lawrence grade from standard weight-bearing ra-
diographs of each symptomatic knee in the pre-HTO
group [15]. A Kellgren and Lawrence grade of 0, 1, 2, 3,
and 4, represented normal, doubtful, minimal, moderate,
and severe knee (tibiofemoral) OA, respectively [15].
The QuIKS
We analyzed the QuIKS, but data were collected on its
35-item prototype questionnaire, as in the initial valid-
ation of the questionnaire, to allow for consistency of
data collection across the study groups [9]. The QuIKS
has 13 items and four subscales, and each item has a 5-
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point rating scale. Some items use an adjectival scale to
quantify frequency (0 = never, 4 = always), while others
use Likert responses from strongly disagree (0) to
strongly agree (4). The 3-item medication subscale cap-
tures medication usage to relieve knee pain. The 3-item
monitoring subscale captures a person’s awareness of
their knee symptoms. The 4-item interpreting subscale
captures one’s understanding of their symptoms. The 3-
item modifying subscale captures an individual’s changes
or intention to change engagement in activity in order
to avoid progressive knee damage. Since each subscale
may operationalize aspects of the lived experience asso-
ciated with early symptoms consistent with knee OA,
combining these subscales into a single measure might
reflect a higher-order construct of these experiences.
This higher-order construct would be expected to be
unidimensional. When normalized, the summative total
scores of the subscales of the QuIKS vary from 0 to 100
(worst to best state).
The KOOS
The Knee injury and Osteoarthritis Outcome Score
(KOOS) is a 42-item knee-specific self-administered
questionnaire [16]. It captures health status in the fol-
lowing five subscales: pain, other symptoms, activities of
daily living, sport and recreation function, and knee-
related quality of life [16]. The total scores of each sub-
scale were normalized to a 0 to 100 (extreme to no
problems) scale. The KOOS has been widely used and
has demonstrated validity, reliability and responsiveness
for adults of all ages with acute and chronic knee pain
problems [17, 18]. The KOOS was chosen to demon-
strate convergent validity of the QuIKS because both
measures have a similar target population. However, the
KOOS evaluates symptoms severity, physical function,
activity in daily living, and quality of life, whereas the




Descriptive characteristics were summarized for the knee
health groups. The Shapiro-Wilk test evaluated normality
of the data within each group of knee health. Factor ana-
lysis and Rasch analysis used only the KP and pre-HTO
groups combined (n = 145), because scores within the HK
group were extreme and would not contribute to these
analyses. Data analyses were performed with SPSS version
20.0 (SPSS Inc, Chicago, Illinois), or other specialized soft-
ware as stated in the upcoming sections.
Factor analysis
As recommended by Tennant and Pallant [19], Horn’s
parallel analysis was performed to determine the number
of factors to extract from the QuIKS prior to its Rasch
analysis [19, 20]. This determined whether the QuIKS
had only a single dominant construct as required for
proceeding to Rasch analysis [19]. A minimum sample
size requirement of 130 participants was calculated using
the 10:1 subject-to-variable rule [21]. Horn’s parallel
analysis used principal components analysis (PCA) with
Monte Carlo simulation to determine the number of fac-
tors in the QuIKS’s data. This was done by identifying
the number of factors with an empirical eigenvalue, in-
cluding their 95 % confidence intervals (CI), that were
greater than the corresponding eigenvalue generated
from 1000 random datasets at a 95 % confidence level
[20]. Horn’s parallel analysis is more accurate than other
forms of factor analysis, such as the eigenvalues-greater-
than-one rule and the scree plot [20]. The 95 % CI of
the empirical eigenvalue for each factor was calculated
using a formula published elsewhere [22]. Following par-
allel analysis, PCA with varimax rotation determined the
percentage variance explained by each factor.
Rasch analysis
Rasch analysis evaluated the fit of the data collected
by the QuIKS to the Rasch model [23, 24]. The
RUMM2030 software (RUMM Laboratories, Perth,
Australia) was used, which is a sophisticated and widely
used software that is specialized for Rasch analysis. An
estimated minimum sample size of 144 subjects was ad-
equate for Rasch analysis for items calibration with ± 0.05
logits at 95 % confidence even if the scale is poorly tar-
geted [25]. However a minimum sample size of 100
subjects is considered to be adequate in most cases at this
confidence level [25].
We hypothesized that the QuIKS would contain a uni-
dimensional dominant construct. We used the following
12 steps and previously published fit criteria for the
Rasch model to investigate this hypothesis [24]. Step 1:
to evaluate goodness-of-fit, the data were divided into
two class intervals using the subjects’ total scores. Step
2: a Fishers Likelihood test was performed. If significant
(P < 0.05 with Bonferroni correction for the number of
items), it suggested that the partial credit model version
of the Rasch model should be used [26]. Step 3: data of
misfitted subjects, those with residual values outside
±2.5, were removed to allow for accurate estimation of
the questionnaire’s measurement properties. Step 4:
response categories were expected to be sequentially or-
dered. Disorder occurred when any response category of
an item always had less than 50 % probability of being
endorsed when compared to each adjacent response cat-
egory. When disordered response categories were identi-
fied, the response structure of the rating scale was
corrected by combining two or more adjacent response
categories. Step 5: the fit of each item was evaluated. An
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items misfitted the model if its residual value was above
+2.5 and/or had a significant chi-square (χ2, P < 0.05
with Bonferroni correction for the number of items in
the questionnaire). Any misfitted item was deleted
because it did not align with the construct captured
collectively by the other items. All the preceding steps
were iterative.
Step 6: the remaining data were evaluated for sum-
mary fit to the Rasch model as defined by a non-
significant item-trait interactive χ2 (P < 0.05 with Bonfer-
roni correction), mean person- and mean item- residual
value (standard deviation) of ~0 (~1). Step 7: each item
was examined for differential item functioning (DIF)
across two subject characteristics considered clinically
relevant to the experiences associated with knee symp-
toms: sex (male/female) and body mass index (i.e., BMI
cut point obese [≥30 kg/m2]/not obese) using two separ-
ate two-way analysis of variance (ANOVA) procedures.
In each two-way ANOVA, the two independent variables
were the subjects’ overall construct estimate divided into
two class intervals and a subject characteristic. Each
item had one mean score for the subjects in each class
interval which formed the dependent variable. An item
with DIF does not provide consistent estimation of the
construct across the categories of the subject character-
istics for subjects with equal overall estimates [24]. Step
8: item pairs with their residual correlation > 0.2 after
mathematically removing the dominant construct, were
considered to have displayed local item dependency,
which means that those items were associated beyond
the dominant construct in the questionnaire [27]. Such
items were combined into a testlet [27].
A testlet is a group of two or more very closely associ-
ated items that give a similar estimate of a subject’s level
of the construct. Testlets are sub-constructs of a scale,
whereas subscales may or may not be sub-constructs.
Step 9: the misfitted subjects’ data (from step 3) were re-
entered and the changes to the QuIKS in step 1 to 6
were repeated. This allowed all subjects who fit the
Rasch-refined QuIKS to be accounted for in the subse-
quent steps of Rasch analysis. Step 10: we formally evalu-
ated whether the dominant construct was unidimensional.
Unidimensionality is a vital component for interval-
level measurement. In the context of testlets, the con-
struct was the common variance (A) among the testlets
[27, 28]. Each subject had an estimate generated for two
exclusive sets of items, using the Smith method [29].
The two estimates for each subject were then compared
using an independent t-test [29].
Unidimensionality was confirmed if less than 5 % of
subjects had significant t-scores, as estimated by the
lower bound of a binomial 95 % CI [24]. Step 11: reliabil-
ity (or scale precision) was then evaluated using the per-
son separation index (PSI). A PSI value of 0.8 indicated
the questionnaire can distinguish subjects in up to three
levels of the dominant construct, which is the minimum
acceptable level for a measurement scale [30]. Step 12:
targeting of the sample by the refined QuIKS was evalu-
ated. This step investigated whether the spectrum of the
construct captured by the refined QuIKS covered the
spread of the construct in the sample. Ideally, the diffi-
culty thresholds of the items should be adequately spread
to capture the quantity of construct in every subject. Sta-
tistically, this was indicated by a mean person estimate
(standard deviation) of ~1 (~0) when the mean item esti-
mate was zero on the same logit (log-odd units) scale of
the dominant construct. Also in this step, the estimate of
each testlet was determined. This allowed us to deter-
mine the hierarchical order of the testlets on the domin-
ant construct based on their logit scores. Lower logit
scores represented the tendency of an item or testlet to
capture lower levels of the dominant construct. A floor
and ceiling effect was 15 % or more subjects with the
maximum or minimum scores, respectively [31]. When
the QuIKS was adequately validated by Rasch analysis,
we adapted a conversion formula [32], and transformed
its summative total raw scores to interval-level scores.
Confirmatory factory analysis
This was performed to test the factor structure in the
Rasch-validated QuIKS. Version 7.3 of the Mplus soft-
ware (Muthén & Muthén, Los Angeles, California) was
used [33]. Total scores were calculated for the Rasch-
validated QuIKS to allow for testing if there was a
higher-order construct. Model fit was evaluated using
the following fit indices and cut-off criteria for adequate
fit; comparative fit index (CFI, >0.90), the Tucker-Lewis
index (TLI, >0.90), and the root-mean-square error of
approximation (RMSEA, <0.08) [34].
Known-groups analysis
We hypothesized that the total scores from the Rasch-
validated QuIKS would be significantly higher for the
HK versus the KP group (n = 166), and higher for the KP
versus the pre-HTO group (n = 145) with at least a mod-
erate effect size. The estimated sample size was 52 sub-
jects per group for a moderate effect size [35]. We used
the Kruskal-Wallis H test (the non-parametric version of
a 1-way ANOVA) with the Mann–Whitney U test (the
non-parametric version of an independent t-test) for
post-hoc testing because the data had a non-normal dis-
tribution. Effect size (r) from the Mann–Whitney test
was calculated as r = z/√n and then converted to Cohen’s
d = 2r/√(1 - r2), where z was the z-score value obtained
from the Mann–Whitney test and n was the total sample
used in the analysis [36]. A Cohen’s d of 0.41 was con-
sidered small and the minimum effect size for a clinically
relevant effect, 1.15 and ≥2.70 were moderate and strong
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effects, respectively [37]. The 95 % CI of Cohen’s d was
calculated as d ± 1.96*Standard Error [38].
Convergent validity
We hypothesized that a similar degree of moderate correl-
ation would be observed between scores on the Rasch-
validated QuIKS and each subscale of the KOOS. This hy-
pothesis was based on reasoning that the KOOS subscales
should be substantially related to a measure that quantifies
experiences related to early symptoms of knee OA. Spear-
man's rank correlation coefficients (rs) quantified these re-
lationships. The HK group was excluded to prevent errors
in rs that would be caused by these subjects' extreme
scores. Moderate correlation of rs ≥ 0.5 supported conver-
gent validity [39]. This analysis required an estimated
sample size of 129 subjects, calculated using rs of 0.7
(95 % CI = 0.5, 0.9) at an alpha value of 0.05, which was
adequately met by the present study's sample [40].
Results
Sample characteristics
Response rate was 63.0 % for the KP and pre-HTO
group, and not applicable to the HK group [9]. The sam-
ple characteristics are summarized in Table 1. Females
were less represented in the pre-HTO group in compari-
son to the KP group.
Number of factors
Table 2 shows the results of the Horn’s parallel analysis
which indicated that only the first factor was suitable for
extraction from the QuIKS’s data and accounted for
45.9 % of the total variance in its score. Therefore, the
QuIKS contained a single dominant construct.
Data fit to the Rasch model
Rasch analysis used the partial credit model. The main
results of Rasch analysis are summarized in Table 3.







(pre-HTO), n = 34
Knee pain and pre-HTO,
n = 145
Age, years
Mean (SD) 24.7 (4.4) 52.1 (6.8) 48.9 (6.5) 51.3 (6.8)
Sex
Female (%) 35 (63.6) 62 (55.4)a 9 (36.0) 71 (49.0)
BMI, kg/m2
Mean (SD) 22.9 (3.1) 28.1 (9.1) 29.1 (4.7) 28.3 (8.3)
Affected knee
Unilateral (%) 1 (1.8) 61 (55.0) 18 (52.9) 79 (54.5)
Bilateral (%) 4 (7.3) 49 (44.1) 16 (47.1) 65 (44.8)
None (%) 50 (90.0) 1 (0.9) 0 1 (0.7)
Family history of arthritis
Yes (%) 23 (42.6)a 52 (46.8)a 11 (33.3)a 63 (43.4)b
History of knee injury
Yes (%) 3 (5.5) 77 (69.4)c 23 (71.9)b 100 (69.0)d
History of knee pain
Yes (%) 2 (3.6) 51 (45.9) 32 (100)b 83 (57.2)e
Kellgren and Lawrence Grade, Number of knees with Grade 0/1/2/3/4 – – 0/10/20/11/4 –
KOOS, range = 0–100 (worst to best state), median (IQR)
Other symptoms 100 (7.1) 53.6 (19.6) 37.5 (29.5) 53.6 (21.4)
Pain 100 (2.8) 80.6 (27.8) 48.6 (23.6) 72.2 (30.6)
ADL 100 (0) 89.7 (23.2) 58.8 (27.7) 80.9 (29.4)
Sport & Recreation 100 (0) 75.0 (40.0) 17.5 (39.1) 58.0 (50.0)
QOL 100 (0) 68.8 (31.3) 15.6 (31.3) 56.3 (43.8)
Kellgren and Lawrence grade severity: 0 (normal) is no OA; 1 (doubtful) is possible joint space narrowing and osteophytes, 2 (minimal) is definite joint space
narrowing and osteophyte, 3 (moderate) is definite joint space narrowing, multiple osteophytes, some sclerosis and possible bone contour deformity, 4 (severe)
is marked joint space narrowing, large osteophytes, severe sclerosis and definite bone contour deformity [20]
BMI body mass index, KOOS knee injury and osteoarthritis outcome score, ADL activities of daily living, QOL quality of life, IQR inter-quartile range
Missing data an = 1, bn = 3, cn = 4, dn = 9, en = 2
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Initially, the QuIKS did not fit the Rasch model. There-
fore, its measurement properties were refined through
eight rounds (runs) of Rasch analysis. One set of modifi-
cations or data manipulation was performed in each run
of Rasch analysis, guided by information obtained in the
preceding runs.
Data of eight misfit persons were deleted. Eight items
had disordered thresholds. There was equitable utilization
of response categories across most items. The exceptions
were items of the medications subscale, for which the
subjects predominantly endorsed the ‘None – 0’ category.
Rescoring the category response structure of all 13 items
from five-level to three-level numeric response categories
resolved all threshold disorder. In this new category re-
sponse structure, the middle three response options have
the same value (0-1-1-1-2), thus assigning an equal score
for the three inner response categories. As an example,
Fig. 1 depicts the category probability curves of one item
of the modifying subscale before and after being rescored.
At this point, no individual item was a misfit. The
data met summary fit criteria to the Rasch model and
there was no DIF. However, the residual correlation
matrix of the items indicated that the four subscales
had local item dependency which grouped the items
into their respective subscales. Only one pair of items
of the interpreting subscale had residual correlations
>0.2, but its items were still considered a testlet because
their residuals were most correlated with each other. The
results from Horn’s parallel analysis coupled with these re-
sults, suggested that the dominant construct in the QuIKS
is a higher-order factor, while its subscales are lower-order
factors. Existing theory, prior research and the preceding
results in this study guided our decision to form four test-
lets corresponding to the original four subscales. There
was a large proportion of common variance (A = 0.93)
among the testlets, which indicated that a single dominant
construct was captured by the QuIKS. After re-entering
the data previously deleted for misfitted persons and mak-
ing the preceding modifications to the QuIKS’s data, only
data of four subjects were deleted; one with an individual
data pattern that misfitted the Rasch model and three sub-
jects with data missing for one item.
This refined QuIKS conformed to the expectations of
summary fit to the Rasch model, as revealed by a non-
significant item-trait interaction χ2, see Table 3. Only 3.0 %
of subjects had significant independent t-tests, confirming
the unidimensionality of the underlying construct in the
refined QuIKS. This Rasch-validated QuIKS had a PSI of
0.82, which is adequate to distinguish up to three distinct
levels of its underlying construct. Figure 2 depicts findings
that suggested the Rasch-validated QuIKS was suitable for
assessing the subjects, because the mean (SD) person
estimate was 0.08 (1.19) with an item estimate mean of
0.00. The subscales of the Rasch-validated QuIKS had a
hierarchical order from less to more knee symptoms-
related experiences in logit scores as follows: monitoring
(−0.886), modifying (−0.192), interpreting (−0.112) and
medication (1.19). There were no floor or ceiling effects.
The Additional file 1 provides the Rasch-validated QuIKS.









1a 5.97 (5.02, 6.92) 1.67 45.9
2 1.35 (1.13, 1.57) 1.49 10.4
3 1.22 (1.03, 1.41) 1.36 9.3
4 1.12 (0.94, 1.30) 1.26 8.6
5 0.69 (0.58, 0.80) 1.18 5.2
95 % CI means 95 % confidence interval
aOnly factor suitable for extraction from the QuIKS
Table 3 Summary fit statistics from Rasch analysis
Version Data changes Sample
size
Item-trait interaction χ2 Item fit residual Person fit residual PSI Significant
t-testsValue (df) P value Mean SD Mean SD
Initial None 145 73.512 (13)* 0.000 0.49 1.84 −0.22 1.18 0.89 7.0
Run 2 Deleted 8 misfit persons 137 72.550 (13) 0.000 0.43 1.93 −0.14 1.01 0.90 5.2
Run 3 Rescored all misfit items 137 19.693 (13) 0.103 −1.01 1.21 −0.66 1.29 0.89 1.6
Run 4a Deleted 20 misfit persons 117 16.105 (13) 0.243 −0.58 1.12 −0.41 1.08 0.90 4.8
Run 5 Formed 4 testlets 117 0.937 (4) 0.92 0.26 0.72 −0.35 0.87 0.84 1.3
Run 6a Used initial data, rescored all items 145 19.480 (13) 0.108 −1.07 1.33 −0.70 1.33 0.89 4.3
Run 7 Formed the 4 testlets again 145 3.546 (4) 0.47 0.02 0.85 −0.45 0.89 0.83 2.9
Run 8 Deleted 1 misfit persons 144 3.612 (4) 0.46 0.03 0.85 −0.43 0.86 0.82 2.9
Rasch-Refined Deleted 3 persons with incomplete data 141 3.613 (4) 0.46 0.00 0.87 −0.44 0.86 0.82 3.0
Criteria of fit to Rasch Model: minimum sample size of n = 108, PSI (Person Separation Index) ≥ 0.80 for reliability assessment by measurement scale,
χ2P-value > 0.05 [Bonferroni-adjusted], Items- and Persons- Fit Residual Mean ~ 0 and SD (Standard Deviation) ~ 1, less than 5 % significant t-test
*Significant after P < 0.05 with Bonferroni correction for the number of items in the analysis
aHad local item dependency
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A table at the bottom of the Rasch-validated QuIKS form
provides the interval-level scores (vary 0 to 100) that
correspond to the total raw scores (vary 0 to 26).
Factor structure of QuIKS
Results from confirmatory factor analysis substantiated
the results from the Horn’s parallel analysis and Rasch
analysis. We tested the one-dominant construct (second
order factor) and four-testlet (first order factors) structure
of the 13-item Rasch-validated QuIKS, and the data
showed adequate fit to the model [CFI = 0.94, TLI = 0.92,
and RMSEA = 0.08 (95 % CI = 0.06–0.10]. Thus, the
Rasch-validated QuIKS conformed to a unidimensional
model.
Known-groups validity
The Kruskal-Wallis H test, where H is the test statistic,
revealed that the total scores on the Rasch-validated
Fig. 1 Category probability curves of one item from the modifying subscale - ‘I participate in certain activities less often to avoid aggravating
my knees’ before formation of the testlets. Panel a: (Before Rescored) depicts disordered response category thresholds. Panel b: (After Rescored)
depicts the item’s response scale after the three inner response categories were rescored to have an equal value of one, thus creating a logical
and sequential ordering of its thresholds
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QuIKS were significantly different among the three knee
health groups (H = 123.01, df = 2, and P < 0.001), with a
median (inter-quartile range) of 100.0 (12.7) for HK,
52.9 (21.4) for KP, and 29.7 (13.8) for pre-HTO. There
was a statistically significant moderate effect size be-
tween the HK and KP groups (n = 166) with Cohen’s d
= 2.20 (95 % CI = 1.81, 2.60), z = −9.615, and P < 0.001,
which indicated less knee symptoms-related experiences
in the HK group compared to the KP group. There was
a significant moderate effect size between the KP and
pre-HTO groups (n = 145) with Cohen’s d = 1.32 (95 %
CI = 0.99, 1.66), z = −6.641, and P < 0.001.
Convergent validity
The QuIKS had statistically significant moderate correl-
ation point estimates of rs between 0.45 and 0.77 with
each KOOS subscale. Its lowest correlation was with the
KOOS-other symptoms (rs = 0.45 [95 % CI = 0.31, 0.57]),
followed by KOOS-sports and recreation function (rs =
0.65 [95 % CI = 0.54, 0.74]), KOOS-activities of daily liv-
ing (rs = 0.70 [95 % CI = 0.60, 0.78]), KOOS-Pain (rs =
0.72 [95 % CI = 0.63, 0.79]), and its highest correlation
was with KOOS-quality of life (rs = 0.77 [95 % CI = 0.69,
0.84]).
Discussion
Our findings affirmed the hypotheses in this study. An
updated version of the QuIKS, called the QuIKS-R, was
adequately validated using information from Rasch ana-
lysis. The results suggest that the QuIKS-R encapsulates
all four of its subscales into a unidimensional measure of
experiences associated with early symptoms that are
consistent with symptomatic knee OA. For clinicians
and researchers, these findings mean that ratings on the
QuIKS-R can be validly summed, much like marks on a
ruler. First, calculate the total raw score, then use the
conversion table at the bottom of the QuIKS-R (see
Additional file 1) to obtain the corresponding interval-
level (final) total score. These interval-level scores are an
individual’s level of knee symptoms-related experiences.
To the best of our knowledge, the QuIKS-R would be
the first unidimensional measure designed to quantify
experiences specifically associated with early symptoms
of symptomatic knee OA [41, 42].
It made conceptual sense to condense the three middle
response categories of each item, given the descriptors
used for these categories. In the medication subscale we
combined ‘Rarely’, ‘Sometimes’, and ‘Often’. We did this
because it might have been difficult for subjects to recall
Fig. 2 Fitting persons and items threshold distribution on the same logit scale. The distribution of the subjects’ estimate of knee
symptoms-related experiences is in the upper histogram, with increasing levels of knee symptoms-related experiences from left to right
on the x-axis. The lower histogram shows the distribution of the 13 items’ response categories threshold estimates, with higher levels of
knee symptoms-related experiences from left to right on the x-axis
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their illness response and then choose a response category
that best classified their experience. It is possible that
subjects did not have a consistent pattern of selecting be-
tween ‘Rarely’ and ‘Sometimes’ and between ‘Sometimes’
and ‘Often’. Perhaps more clearly defined descriptors, for
example, ‘Rarely = 1 to 3 times per week’, ‘Sometimes = 4
to 6 times per week’, and ‘Often = 7 to 9 times per week’
would remove ambiguity from among these categories
[43]. Furthermore, the other 10 items used five-point
Likert scales with ‘Neutral’as their midpoint. The rescoring
of these items could be explained in the context of the
long history of debate on the implication of midpoints in
rating scales [44]. A midpoint, such as ‘Neutral’, is some-
times misinterpreted or selected in a biased way [44].
However, its removal might push some respondents to
choose adjacent categories and reduce the reliability and
validity of the measure [44]. Therefore, scoring the mid-
point in the same manner as its adjacent categories was
deemed a good solution for these two issues.
Based on the hierarchical order of the logit scores of the
subscales (testlets), this study suggests that the level of
knee symptoms-related experiences increased as individ-
uals moved from the monitoring, to the modifying, then
interpreting, and finally to the medication subscale. This
pattern means that subjects tended to indicate higher
ratings on the monitoring subscale compared to the medi-
cation subscale. This pattern fits with a grounded theory
of experiences and behaviour that people with emergent
chronic knee problems engage in to prevent damaging
their knee, a theory called ‘Being Careful’ that describes
“the process of recognising the onset of chronic knee
problems” (p. 939) [5]. This pattern also fits with the
model of illness behaviour which is a representation of the
decision-making process during an illness [45]. This
model employs nine stages, starting from illness recogni-
tion and labeling to the application of treatment with
consequential re-evaluation of the illness state by the indi-
vidual, in an iterative process [45]. Furthermore, the
model of selective optimization with compensation
[46] also offers a theoretical basis for why items from
different subscales form a unidimensional construct in
the QuIKS-R, as it provides an explanation of the
process of adaptation in people with knee pain prob-
lems. For example, in the early stages of symptomatic
knee OA, one would expect that a person might make
the decision to stop engaging in a favorite activity
because of their knee pain (selection), change their
exercise routine because of the knee problem (com-
pensation), and take medication before activity to pre-
vent pain (optimization) [46, 47]. For clinicians these
findings mean that scores on the QuIKS-R covers a
continuum of knee symptoms-related experiences in
people with knee symptoms that are consistent with
symptomatic knee OA.
Forming testlets to obtain unidimensionality demon-
strated that the subscales of the QuIKS are sub-constructs
of a unified set of complex experiences in people with
knee symptoms. When measuring a construct, measures
with fewer items tend to have higher accuracy but lower
precision [13, 14]. By forming the testlets, we were able to
capitalize on the accuracy of the subscales, while capitaliz-
ing on the precision of the full questionnaire to provide
more information about an individual’s level of knee
symptoms-related experiences. It is worth noting that the
individual testlets should not be used for score interpret-
ation. Only total scores from all 13 items of the QuIKS-R
should be interpreted, and this interpretation should
be in the context of the higher-order construct of
knee symptoms-related experiences.
The QuIKS-R discriminated between the study groups.
The pre-HTO group had the highest level of knee
symptoms-related experiences, followed by the KP, then
the HK group, with a significant between-group differ-
ence of at least a moderate effect size. There are no pre-
vious studies of the QuIKS with which to compare these
findings. However, population-based reference data of
each subscale of the KOOS supports the values obtained
in the present study [48, 49]. For example, the KOOS-
pain median score for the KP and pre-HTO groups were
80.6 and 48.6 respectively, and 97.2 for people aged 35
to 54 years in a population-based group [48]. This is
logical given that the prevalence of symptomatic knee
OA increases with age and OA-related knee pain usually
becomes more severe over time [3, 50]. A lower correl-
ation between the QuIKS-R and the KOOS-other symp-
tom subscale compared to the QuIKS-R correlation with
the other KOOS subscales, could mean that the level of
knee symptoms-related experiences in the study popu-
lation was less related to other joint impairments but
highly related to pain severity, activity limitations and
knee-related quality of life. Nevertheless, the significant
moderate correlations between the scores on the QuIKS-R
and each subscale of the KOOS, suggest that there are
important relationships between the constructs in the two
measures. For clinicians, these findings could mean that
the QuIKS-R may be useful in discouraging physical activ-
ity limitations while helpful in promoting or maintaining
physical activity and quality of life in patients with knee
symptoms consistent with symptomatic knee OA.
A major implication of the current study is that the
QuIKS has now adequately achieved construct validation
through creation of the QuIKS-R. Whereas the original
QuIKS had ambiguity across the categories of each
item’s response scale and was not unidimensional, the
QuIKS-R is unidimensional and provides interval-level
scores. These interval-level scores mean that equal unit
differences along the QuIKS-R scale represent equal
amounts of its underlying construct, regardless of where
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on the scale these differences occur. Overall the findings
in the current study imply that the QuIKS-R has
adequate discriminative ability. The QuIKS-R may be
used as a discriminative tool but has not been validated
as an evaluative measure. Also, whereas the original
QuIKS is a “self-administered questionnaire used to pro-
mote activity by identifying the experiences associated
with early symptoms consistent with knee OA” (p. 1)
[9], the QuIKS-R shares this purpose by using a more
refined scale.
Limitations and future research
A limitation of this study was that the subjects in the KP
group did not receive a medical diagnosis, so their knee
pathology could be unrelated to knee OA. Also, while
known-group (discriminative) validation supported the
QuIKS-R ability to discriminate the level of knee
symptoms-related experiences between healthy and two
severely involved groups, this information might not be
useful for a clinician’s assessment of individual patients.
Future studies should use a larger sample and evaluate
the predictive validity of the QuIKS-R in identifying sub-
jects with OA-like knee pain who are at greatest risk for
physical activity limitations.
Conclusions
The QuIKS-R is a unidimensional measurement scale that
provides interval-level scores of knee symptoms-related
experiences in persons with knee symptoms consistent
with symptomatic knee OA. Scores on the QuIKS-R that
represent more knee symptoms-related experiences, also
mean that a patient is more aware of and affected by their
knee symptoms, and has tried more to remedy their
condition. This information might be useful for clinicians
when providing pain management interventions and for
promoting activity in individuals with early symptoms
consistent with symptomatic knee OA.
Additional file
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